Epi proColon®

In the US, 1 in 3, or 23 million eligible people are not screened for colon cancer.

As a consequence, 60% of colon cancer cases are diagnosed at a late stage, when the cancer has already spread and treatment becomes more challenging.

For those people who have a history of not completing screening by guideline recommended methods, there is now a blood test. Epi proColon is the first and only FDA approved blood test for colon cancer screening. Benefits of Epi proColon include:

• No pretest preparation

• No stool handling

• No dietary or medication restrictions

• Available through national laboratories

Please select your Language:

Verwendung von Cookies: Um unsere Webseite für Sie optimal zu gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Weitere Informationen zu Cookies erhalten Sie in unserer Datenschutzerklärung.Use of cookies: We use cookies to make our website optimal for you and to be able to continuously improve it. By proceeding to use the website, you agree to the use of cookies. Further information on cookies can be found under data protection.Ok